Page 1030 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

71. van Dissel JT, van Langevelde P, Westendorp RG, et al. 89. Nakos G, Malamou-Mitsi VD, Lachana A, et al. Immunoparalysis
Antiinflammatory cytokine profile and mortality in febrile in patients with severe trauma and the effect of inhaled interferon-
patients. Lancet. 1998;351:950-953. gamma. Crit Care Med. 2002;30:1488-1494.
72. Hynninen M, Pettila V, Takkunen O, et al. Predictive value of 90. Allen ML, Peters MJ, Goldman A, et al. Early postoperative
monocyte histocompatibility leukocyte antigen-DR expression monocyte deactivation predicts systemic inflammation and
and plasma interleukin-4 and -10 levels in critically ill patients prolonged stay in pediatric cardiac intensive care. Crit Care
with sepsis. Shock. 2003;20:1-4. Med. 2002;30:1140-1145.
73. Monneret G, Finck ME, Venet F, et al. The anti-inflammatory 91. Hotchkiss RS, Swanson PE, Cobb JP, et al. Apoptosis in lym-
response dominates after septic shock. Immunol Lett. 2004; phoid and parenchymal cells during sepsis. Crit Care Med.
95:193-198. 1997;25:1298-1307.
74. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10. Crit 92. Hotchkiss RS, Chang KC, Swanson PE, et al. Caspase inhibitors
Care Med. 2002;30:S58-S63. improve survival in sepsis: a critical role of the lymphocyte.
75. Sfeir T, Saha DC, Astiz M, et al. Role of interleukin-10 in mono- Nat Immunol. 2000;1:496-501.
cyte hyporesponsiveness associated with septic shock. Crit Care 93. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic
Med. 2001;29:129-133. cell death in patients with sepsis, shock, and multiple organ
76. Muehlstedt SG, Lyte M, Rodriguez JL. Increased IL-10 produc- dysfunction. Crit Care Med. 1999;27:1230-1251.
tion and HLA-DR suppression in the lungs of injured patients 94. Hotchkiss RS, Chang KC, Grayson MH, et al. Adoptive transfer
precede the development of nosocomial pneumonia. Shock. of apoptotic splenocytes worsens survival, whereas adoptive
2002;17:443-450. transfer of necrotic splenocytes improves survival in sepsis. Proc
77. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: Natl Acad Sci USA. 2003;100:6724-6729.
endotoxin tolerance as a model of leukocyte reprogramming in 95. Le Tulzo Y, Pangault C, Gacouin A, et al. Early circulating
sepsis. Crit Care. 2006;10:233.
lymphocyte apoptosis in human septic shock is associated with
78. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced poor outcome. Shock. 2002;18:487-494.
apoptosis causes progressive profound depletion of B and CD4+ 96. Holub M, Kluckova Z, Helcl M, Prihodov J, Rokyta R, Beran O.
T lymphocytes in humans. J Immunol. 2001;166:6952-6963. Lymphocyte subset numbers depend on the bacterial origin of
79. Venet F, Chung CS, Kherouf H, et al. Increased circulating sepsis. Clin Microbiol Infect. 2003;9:202-211.
regulatory T cells (CD4(+)CD25 (+)CD127 (−)) contribute to
lymphocyte anergy in septic shock patients. Intensive Care Med. 97. Roth G, Moser B, Krenn C, et al. Susceptibility to programmed
2009;35:678-686. cell death in T-lymphocytes from septic patients: a mechanism
for lymphopenia and Th2 predominance. Biochem Biophys Res
80. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: Commun. 2003;308:840-846.
endotoxin tolerance as a model of leukocyte reprogramming in
sepsis. Crit Care. 2006;10:233. 98. Venet F, Davin F, Guignant C, et al. Early assessment of leu-
kocyte alterations at diagnosis of septic shock. Shock. 2010;
81. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mecha- 34(4):358-363.
nisms, molecules and clinical significance. Trends Immunol.
2009;30:475-487. 99. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia
82. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. and bacteraemia in UK adults with medical emergencies. J Clin
Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Pathol. 2004;57:950-955.
Res. 2005;11:311-320. 100. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith
83. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. CM, Karl IE. Accelerated lymphocyte death in sepsis occurs
Dysregulation of in vitro cytokine production by monocytes by both the death receptor and mitochondrial pathways.
during sepsis. J Clin Invest. 1991;88:1747-1754. J Immunol. 2005;174:5110-5118.
84. Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM. 101. Hershman MJ, Cheadle WG, Wellhausen SR, Davidon P,
Dissociation between plasma and monocyte-associated cyto- Polk HC. Monocyte HLA-DR antigen expression character-
kines during sepsis. Eur J Immunol. 1991;21:2177-2184. izes clinical outcome in the trauma patients. Br J Surg. 1990;
85. Koppelman B, Neefjes JJ, de Vries JE, et al. Interleukin-10 down- 77:204-207.
regulates MHC class II αβ peptide complexes at the plasma 102. Strohmeyer JC, Blume C, Meisel C, et al. Standardized immune
membrane of monocytes by affecting arrival and recycling. monitoring for the prediction of infections after cardiopulmo-
Immunity. 1997;7:861-871. nary bypass surgery in risk patients. Cytometry. 2003;53:54-62.
86. Astiz M, Saha D, Lustbader D, et al. Monocyte response to 103. Venet F, Lepace A, Monneret G. Monitoring immune dys-
bacterial toxins, expression of cell surface receptors, and release function in septic patients: toward tailored immunotherapy.
of anti-inflammatory cytokines during sepsis. J Lab Clin Med. In: Vincent J-L, ed. Yearbook of Intensive Care and Emergency
1996;128:594-600. Medicine. Berlin, Heidelberg: Springer-Verlag; 2009:81-89.
87. Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in 104. Cavaillon JM, Adib-Conquy M. Determining the degree
septic patients: restoration by IFN-gamma treatment. Nat Med. of immunodysregulation in sepsis. Contrib Nephrol. 2007;
1997;3:678-681. 156:101-111.
88. Lukaszewicz AC, Grienay M, Resche-Rigon M, et al. Monocytic 105. Meisel C, Schefold JC, Pschowski R, et al. GM-CSF to reverse
HLA-DR expression in intensive care patients: interest for sepsis-associated immunosuppression: a double-blind randomized
prognosis and secondary infection prediction. Crit Care Med. placebo-controlled multicenter trial. Am J Respir Crit Care Med.
2009;37:2746-2752. 2009;180:640-648.

Section05-O-ref.indd 3 1/20/2015 4:51:16 PM